And on the healthcare utilization broadly front, as we talked about in the last earnings call, we've seen that largely return to normal, which is great on the flu front, I think it's a little too early to predict, but the reason both of those dimensions matter so much is that consumer interactions with the healthcare community are a key driver for us of our own growth. That hybrid model really lets us ensure network stability, the -- we want to make sure we don't have -- and we anticipate -- we don't anticipate having any similar issue. You see that in insurance, you see it in financial services. Our next question comes from Koji Ikeda with Bank of America. I think over the short term, we have seen some inflation as the rest of the country has with everything. balance sheet and inputs from the stock market. So I'll assume and it would be great if you could confirm that they're more or less in line with what they've been historically. So, Anthony, good question. During third quarter, we are pleased to see, with the exception of the particular grocer, that volumes did increase 5% quarter over quarter. We now list revenue headcount and industry classifications for 100% of companies, including their NAICS and SIC codes. Again, we look at everything in concert, and we look at everything together. This is the result of the volume and value we efficiently drive for our PBM partners. This article is a transcript of this conference call produced for The Motley Fool. It comes from the line of Robert Simmons with D.A. However, in order to maintain the high level of discourse weve all come to value and expect, please keep the following criteria in mind: Stay focused and on track. Morgan Stanley: Overweight: $38: Oct-11-21: Initiated: JP Morgan: Overweight: $37: Oct-11-21: Initiated: Goldman: Neutral: $32: Q3 Earnings and Revenues Top Estimates. *Average returns of all recommendations since inception. This represents 0.1% of the company. Or can you give any perspective on how it looks more compared to the pre-pandemic levels? Genius Group Limited (AMEX:GNS) Q3 2022 Earnings Call Transcript November 30, 2022 Operator: Hello, and welcome to the Genius Group Third Quarter 2022 Financial Results Conference Call and Webcast. Or just any statistics in terms of just kind of where that business stands today? And so, that's what we were getting at with that comment in the press release. Good morning, ladies and gentlemen, and welcome to Genworth Financial's third quarter 2022 earnings conference call. Get all the latest India news, ipo, bse, business news, commodity only on Moneycontrol. Thanks, John. So I think, we continue to see a strong uptake in the advanced functionality, but most of that is upsold to our existing customers. So, I think we'll expect that we'll continue to focus heavily on knowing our consumers better, being able to get more information from them that allows them us to help them more and create products that are even more innovative and even more supportive of their health outcomes. One moment for our next question. But wondering if you could provide just another layer of detail around the renewal discussions. Today, we will be sharing our perspective on our recent performance, but I want to start off by discussing two of our most important priorities, which go hand in hand to help Americans get the healthcare they need at a price they can afford, and as we deliver on that mission to create value for our shareholders. Is that something that would -- that would kind of compress lower in Q4 even kind of despite the potential for some of that budget flush activity? Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. For example, if a prospect from one of your assigned accounts visits a high-value page on your website, we can automatically alert you and attach the relevant account and deal context for immediate outreach. But anything you can add there and around just confident in the ability to return to the targeted levels if that remains the case. ZoomInfo Technologies Inc. (ZI) Q2 2021 Earnings Call Transcript. However, we do not anticipate the trial date to be set until mid-2023. In terms of unlevered free cash flow, we are seeing some flexibility that customers are requiring or asking for in terms of payment schedules. Thank you. This is Karsten again. How could some of those budget conversations and dynamic continued to evolve as you move out of 2022 and into 2023 and supportive evidence of continuing to drive high ROI outcomes for marketers on the platform? Thanks. As we mentioned on our second-quarter earnings call, the strategic repositioning of this offering focuses on the narrower audience, which negatively impacts growth rates, but is anticipated to reduce churn in the longer term. And as I mentioned earlier, we saw the largest expansion and new business deal in the company's history. Got it. And then, can you be a little bit more specific on the retracing of the dollar -- of the net expansion rate? We're certainly not going to see a step function in margins go up, and I do think where we expect a steady increase in the margins as we realize the operating leverage. And the series of actions we've been taking is what enabled us to exceed expectations this quarter, in particular on adjusted EBITDA. Net loss was $41.7 million, compared to a net loss of $18.1 million in 3Q 2021. We continue to make significant progress in addressing risk in our legacy LTC portfolio through the multiyear rate action plan, as you can see on Slides 10 through 12. And we've been excited about the progress we've made in deepening those relationships and taking advantage of those opportunities to expand the number of brands we serve and expand the number of different solutions they're using from GoodRx. ET. Allowing consumers to provide us with more information through registration increases, the LTV of each user in prescription transactions and other areas of the business over time as we leverage data to create new tools and products in quarters and years to come. Thanks so much for taking my question. Adjusted EBITDA margin of approximately 28% declined 390 basis points year over year, but improved quarter over quarter and exceeded the 3Q guidance we provided in August given the one-time reduction-in-force we completed during the quarter and our focus on marketing efficiency. Also contributing to higher new claim severity is a shift in the claims mix away from home care that people gravitated to during the pandemic, back to higher-cost facility-based care. Throughout the 1980s, shares of Bank of America slowly chugged along, but Bank of America stock price hit an all-time-low on August 12, 1982, when they closed at $1.47. Stock is still a buy in several circles. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. While the Choice 1 legal settlement implementation is materially complete, the second LTC legal settlement related to PCS 1 and 2 policies began on August 1 and covers approximately 15% of our LTC block. We've got obligations over the next 20, 30, 40, 50 years. And I hope that answers the question. While the economic outlook remains uncertain, we remain committed to driving improved margin performance. We're seeing meaningful consolidation uplifts with customers like Ryder and USI and Taylor Corporation, who all consolidated multiple point solutions on to ZoomInfo's RevOS platform. Just as the elevator changed real estate, will the reusable rocket bring opportunities we cant yet imagine? So I would say that we're continuing to, obviously, raise our expectations. Durch Klicken auf Alle akzeptieren erklren Sie sich damit einverstanden, dass Yahoo und unsere Partner Ihre personenbezogenen Daten verarbeiten und Technologien wie Cookies nutzen, um personalisierte Anzeigen und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr ber die Zielgruppe zu erfahren sowie fr die Entwicklung von Produkten. We are also focused on reaccelerating revenue growth in an efficient manner by leveraging our platform to expand margins following the cost reduction initiatives we began in the third quarter.We expect to see meaningful benefits over the long term from our engagement efforts, along with our focus on investing in our fast-growing Pharma Manufacturer Solutions platform. Sure. As we look ahead to the fourth quarter and beyond, Genworth remains prepared to navigate ongoing economic uncertainty due to our well-positioned investment portfolio, very low debt-to-capital ratio modest annual debt service obligations and expected cash flows from Enact. Receive email alerts for IR reports, events, filings, and more. I don't know if -- thanks, Mark. Details. So, when you look at the grocer as having historically represented approximately 20% of volume, just shy of 25% of revenue to where they are today that much lower percentage today in the very low single-digits, even if it's growing slightly, doesn't really impact the aggregate number -- dollar number associated with the amount of revenue that we've forgotten with the grocer. You said you're partnering with. From the moment the healthcare provider writes the prescription through to the period when the consumers actually benefiting from receiving it at the pharmacy, including managing a lot of the complexity that exists, particularly for insured patients around things like step therapies and preauthorization and the like. ET. And that certainly in the short term has an impact on the conversion of free cash flow from adjusted operating income. And part of that is just natural operating leverage in the sales and marketing side as growth moderates, but we should see sales and marketing as a percentage of revenue go down when that happens. So, the strength of our brand and just the really solid work being done there has showed us that we can be more efficient there and we continue to see opportunities there. As of October 2017, the company owns 700 million shares of Bank of America stock, valued at over $18 billion. So, focusing on the first part of the question initially, yes, you heard us quite correctly. [Operator instructions] We'll take our next question from Tom Slattery with Morgan Stanley. We can communicate price improvements for their client prescriptions. Then secondly, we're penetrated into approximately call it 10% or 15% of U.S. manufacturers period. So, thanks for the great question. This includes our new meeting brief that help our customers run effective meetings by pushing company, participants and competitive intelligence along with deal risks and engagement highlights right to our customers' inbox. Jonathan Yong -- Credit Suisse -- Analyst. We will continue to monitor the situation between now and when we do our upcoming earning call at the beginning of 2023 to continue to refine our reviews on how that year will evolve. For Enact, continued rising rates will drive higher persistency and a meaningful benefit to the portfolio yield due to the shorter duration of the mortgage insurance portfolio. Coupang, Inc. (CPNG) Q2 2021 Earnings Call Transcript. Daily Bulletin.com covers local news from Pomona to Ontario including, California news, sports, things to do, and business in the Inland Empire. An example, we are especially excited about is a new collaboration with Express Scripts to support them in their mission to make prescription medicines more affordable for their members. Number one, we're extremely pleased that GoodRx discounts are welcomed at Kroger. When we're selling a consolidated platform, there is a slightly longer sales cycle as we're displacing numerous point solutions. Date. 05 2021. And on top of that, there are offsets to inflation. I think in the interim period right now, as we alluded to in the scripted remarks as well, pharma manufacturers are taking more time to make decisions around spend, and given that at year-end, in particular, the deals can be quite significant in size, amounting to millions or sometimes even $10 millions -- tens and millions of dollars in one deal, that catalyzes potential fluctuation around year-end. Doug Anmuth -- JPMorgan Chase and Company -- Analyst. Q3 2022 Earnings Call Nov 10, 2022, 7:00 a.m. My name is Karen, and I will be your coordinator today. Feb. 04 2021 Mar. I think to the other part of your question, which goes to how that could evolve going forward and whether the gap will close. Replace the attached chart with a new chart ? You may recall a 2021 survey we conducted of over 4,000 GoodRx and GoodRx Gold users that found that 85% of consumers surveyed agreed that their positive experience with GoodRx at their preferred pharmacy makes them want to return to that pharmacy more often. OK. And just one follow-up. I sold my late mother's home for $250,000. Understood. I think, teams across the world are saying, how do I grow without adding headcount? It was a little hard to hear you, so I'll do my best to touch on each part of that question. Is that the correct number? EPS was approximately in line with expectations but dropped significantly vs Q3 in 2021. And then, the second part of your question was? Hey, Sandy, great to speak with you, and thanks for the question as well. I wanted to follow up on the payment flexibility that you noted. Q3 2022 Earnings Call Nov 02, 2022, 9:00 a.m. That held largely true through the first nine months. But if I look at your 4Q guide, you're essentially guiding for little improvement on a sequential basis. I'm curious, in this case, just given kind of the slowdown you're talking about, is that a decent barometer for kind of organic bookings growth? Of course, grocer issue is one headwind on a year-over-year basis. We're very excited about where this new platform is heading, and we look forward to providing you with updates on how it is furthering our mission and driving revenue in the quarters to come. The Motley Fool has a disclosure policy. I had a couple of questions on long-term care. We've also layered in provider mode, which is a tool that allows providers to, for example very rapidly share GoodRx discounts directly with their patients without sharing their personal email address or phone number. I think the other aspect of that is that, if deals are delayed, then the delivery on them also gets pushed out. Morgan Stanley When Morgan Stanley reports Friday, October 14th, the consensus is expecting $1.49 in EPS on $13.2 billion for expected YoY declines of 27% and 10% respectively. Meaning that we don't see a return to 20%-ish of volume and nearly 25% of revenue. We continue to build a new entrepreneurial management team in our global care solutions business. They're moving back into facilities. So, first of all, in the context of the top 20, while we are in top 19 of the top lens, the number of solutions we're offering to manufacturers and the number of medications at each manufacturer that we're able to help drive volume on those opportunities continue to grow over time. Helpful color there. [Operator signoff]. The single A bond rate as of the January 1, 2021 transition date was materially lower than our discount rate of over 5% under the existing guidance. So, we only saw about half the impact we'd expect to see in the fourth quarter. & Head-US Private Markets Business, President-Global Corporate & Investment Banking, President-Preferred & Consumer Banking & Invts, ice Chair of the Board & Chief Financial Officer, Registration on or use of this site constitutes acceptance of our. These results were again led by Enact, which reported $156 million in adjusted operating income to Genworth. In the third quarter, we further improved our financial strength delivering solid results while reducing debt. It will have no impact on our cash flows, statutory accounting, capital position, capital returns or business strategy for our U.S. life insurance companies. We had $728.8 million in cash and cash equivalents on the balance sheet and $668.8 million in outstanding debt as of the end of the third quarter. Please go ahead. The Motley Fool has no position in any of the stocks mentioned. Invest better with The Motley Fool. A presentation detailing the Q3 2022 earnings can be found on the company 2021 and other reports filed with the SEC. Yeah. An example of just one of the expected benefits is our increasing ability to direct users to the retailer that best fits their needs, especially as their needs and prescription pricing change over time. The amount of prescription transactions revenue associated with the grocer decreased from $12.4 million to $4.3 million during this period and is still well under the $33.7 million from third quarter 2021, as well as the $37.7 million we earned in connection with the grocer in the first quarter of 2022. Turning to Slide 13 and our life insurance product. I will talk more about this shortly, but I wanted to first touch on the progress we've made toward driving value for shareholders. During the first 9 months of 2022, we received LTC in-force rate action approvals impacting $610 million of annualized in-force premiums with a weighted average increase of 33%. Is the $28.7 billion is the goal you guys are trying to hit? Koji Ikeda -- Bank of America Merrill Lynch -- Analyst. Key cash activity included an inflow of $64 million from intercompany tax payments and the $19 million dividend from Enact as well as the outflow for the 2024 debt redemption of $154 million, which included $2 million in the make-whole premium. As a result of the more challenging environment, we now expect dollar-based net retention in 2022 to retrace the gains that we were able to achieve in 2021. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. These elements, particularly EBITDA and cash conversion are largely in our control. If you are analyzing similar metrics, it is important to remember that the comparative period of Q3 2021 should be adjusted for acquisitions. Q3 AT&T Earnings Conference Call. And why we shouldn't be too worried about this as a leading indicator and something that could maybe spread to a slowdown at the core. Thursday, October 21, 2021 Monday, May 24, 2021 Supporting Materials. I want to buy a house. I think there are a couple of dynamics to articulate. Data ranges from 2021-12-06 00:00:00 to 2022-12-05 14:13:52. That's right -- theythink these 10stocks are even better buys. However, I think some in the investment community became a little bit confused when, Kroger announced back on September 30th that their dispute between themselves and the Express Scripts was still not resolved and without a resolution by December 31, their commercial contract would be terminated. So, in those two dimensions, I think we see the reality is one in which timing may be more questionable than it was in the past, but the overall attractiveness of the market for GoodRx's as high as it ever was, potentially even higher with the continued shift to digital now being confirmed, I think through the recent surveys we're seeing. We're very proud of the progress we've made on our long-term value-creation strategy. Q2 2021 Earnings Call Transcript. In our LTC business, adjusted operating income was $25 million, compared to $34 million in the prior quarter and $133 million in the prior year. But as we expand those accounts, our expansion motion is much more focused on selling a holistic platform story. And do you continue to invest? Market Value $41.298 Million ; Prior Market Value $3.309 Million; New Purchases 5 stocks; Additional Purchases 1 stock; Sold out of 0 stocks; Reduced holdings in 0 stocks; Top 10 Holdings % 100.00 % Turnover % [1]: 83.33% Turnover Alt % [2]: % Time Held Top20: 0.17 quarters Time Held Top10: 0.17 quarters Time Held All: 1.17 quarters Other strategic initiatives continue to perform well. A presentation detailing the Q3 2022 earnings can be found on the company 2021 and other reports filed with the SEC. So, we're driving all these additional benefits. 4 Growth Stocks I've Aggressively Bought Before the Next Bull Market Begins, Join Nearly 1 Million Premium Members And Get More In-Depth Stock Guidance and Research, Copyright, Trademark and Patent Information. ZoomInfo can identify technologies across more than 200 technology categories, including a company's CRM, corporate performance management system or even their travel and expense management system. CFO Pascal Desroches at Morgan Stanley Conference, 4.750% Perpetual Preferred Stock, Series C Dividend Payment Date - $296.875 per preferred share, or $0.296875 per depositary share, 5.000% Perpetual Preferred Stock, Series A Dividend Payment Date - $312.50 per preferred share, or $0.3125 per depositary share, Common Shares Dividend Payment Date $0.2775, 4.750% Perpetual Preferred Stock, Series C Dividend Record Date - $296.875 per preferred share, or $0.296875 per depositary share, 5.000% Perpetual Preferred Stock, Series A Dividend Record Date - $312.50 per preferred share, or $0.3125 per depositary share, Common Shares Dividend Record Date $0.2775, CEO John Stankey at Goldman Sachs Conference, CFO Pascal Desroches at Bank of America Conference, Jeff McElfresh Fireside Chat at Bank of America C-Suite TMT Conference, Pascal Desroches Fireside Chat at Credit Suisse Annual Communications Conference, John Stankey at J.P. Morgan Global Technology, Media & Communications Conference, Fixed Rate Reset Perpetual Preferred Stock, Series B Dividend Payment Date -2,875.00 per preferred share, Fixed Rate Reset Perpetual Preferred Stock, Series B Dividend Record Date -2,875.00 per preferred share, AT&T Distribution Dividend to Spin Off Interest in WarnerMedia to Shareholders, Pascal Desroches at Deutsche Bank Media, Internet & Telecom Conference, Common Shares Dividend Payment Date - $0.52, Common Shares Dividend Record Date - $0.52, Pascal Desroches at Barclays Global Technology, Media and Telecommunications Conference, John Stankey at UBS Global TMT Conference, Jeff McElfresh at Wells Fargo Technology, Media and Telecom Summit, Pascal Desroches at Morgan Stanley European Technology, Media & Telecom Conference, John Stankey at Goldman Sachs Communacopia Conference, Pascal Desroches at Bank of America Media, Communications & Entertainment Conference, Pascal Desroches at Oppenheimer Annual Technology Conference, Common Share Dividend Payment Date - $0.52, Common Share Dividend Record Date - $0.52, AT&T at Barclays Future of Media Conference, AT&T at Bernstein Strategic Decisions Conference, AT&T at Cowen Technology, Media & Telecom Conference, Fixed Rate Reset Perpetual Preferred Stock, Series B Dividend Payment Date - 3,448.42896174863 per preferred share, Fixed Rate Reset Perpetual Preferred Stock, Series B Dividend Record Date - 3,448.42896174863 per preferred share, John Stephens at Citi Global TMT Conference, Igal Elbaz at Oppenheimer 5G Summit on December 15, Scott Mair at Barclays Global Technology, Media and Telecommunications Conference on December 9, John Stankey at UBS Global TMT Conference on December 8, John Stephens at Morgan Stanley European Media, Tech and Telecom Conference, Q3 2020 AT&T Inc. Earnings Conference Call, John Stankey at WSJ Tech Live Conference on October 19, AT&T at Goldman Sachs Communacopia Conference, Q2 2020 AT&T Inc. Earnings Conference Call, Q1 2020 AT&T Inc. Earnings Conference Call, Q4 2019 AT&T Inc. Earnings Conference Call, Q3 2019 AT&T Inc. Earnings Conference Call, Q2 2019 AT&T Inc. Earnings Conference Call, Q1 2019 AT&T Inc. Earnings Conference Call, Q4 2018 AT&T Inc. Earnings Conference Call, Q3 2018 AT&T Inc. Earnings Conference Call, Q2 2018 AT&T Inc. Earnings Conference Call, Q1 2018 AT&T Inc. Earnings Conference Call, Q4 2017 AT&T Inc. Earnings Conference Call, AT&T Press Conference on Time Warner Merger, Q3 2017 AT&T Inc. Earnings Conference Call, Q2 2017 AT&T Inc. Earnings Conference Call, AT&T Inc. 2017 Annual Meeting for Stockholders, Q1 2017 AT&T Inc. Earnings Conference Call, Q4 2016 AT&T Inc. Earnings Conference Call, AT&T Acquisition of Time Warner and 3Q16 Results, Q2 2016 AT&T Inc. Earnings Conference Call, Q1 2016 AT&T Inc. Earnings Conference Call, Q4 2015 AT&T Inc. Earnings Conference Call. Dan, do you want to just comment on in order to repurchase the 66 in the open market. And so it creates no sense of urgency from our perspective. All Rights Reserved. I want kind of flip that. First, I just wanted to start with -- you talked about this metric of 30% of ACV coming from advanced functionality and it continues to go in the right direction, but that seems to be only up slightly from Q2 when it was 29%. Avoid profanity, slander or personal attacksdirected at an author or another user. Zacks. So gross churn actually hung in very well despite the macroeconomic environment. Thank you, Jerry, and welcome, everyone. Please wait a minute before you try to comment again. Craig Hettenbach -- Morgan Stanley -- Analyst. And so, you'll see some continued improvements there as we try to make that program applicable a broader and broader set of users and start increasing subscriber numbers again. The Choice 2 block is the largest over 300,000 policies. And so, from an international perspective, we still are seeing growth, again, stronger than the accelerated growth relative to the rest of our business. Under this new program eligible Express Script members get access to GoodRx prices as part of their pharmacy benefit. We continue to stabilize and further grow our retail network, worked with retailers and pharmacy benefit managers on finding more ways to offer even better consumer prices, expanded our content offerings, and enhanced our provider-focused offerings to make it even easier for providers to be great advocates for GoodRx. So if people had they were taking care of somebody in the house. Q3 2022 Earnings Call Nov 02, 2022, 9:00 a.m. Based on the preliminary work done to date, our assumptions appear to be holding up in the aggregate, and we do not currently anticipate significant assumption changes or resulting significant financial impacts from these reviews. Hey, guys, thanks for taking my questions. But new business continues to do well, much better, I think, relative to the historical trend, whereas the capacity on the AM side is a short-term impact that we see from the macroeconomic challenges. Economic Events and content by followed authors. Thanks for taking my question. And so, that would be the area where we continue to invest. To make the world smarter, happier, and richer. But certainly, the attitude of customers is that they are looking for more flexibility, as they're dealing with similar pressures to we are in terms of macroeconomic challenges. Expressions of future goals, including business outlook, expectations for future financial performance and similar items, including, without limitation, expressions using the terminology may, will, expect, anticipate and believe and expressions, which reflect something other than historical facts, are intended to identify forward-looking statements. Thank you. [Operator instructions] Ladies and gentlemen, as there are no further questions, I will now turn the call back over to Mr. McInerney for closing comments. Adjusted net income decreased 25% year over year to $29.9 million. Here's the 1 Social Security Change in 2023 That's Going to Hurt the Worst. I'll jump in and talk a little bit about some of the things we're excited about with regard to engaging with our, both our consumers, as well as physicians, more and more tightly. The change in the NRR aspect has much more to do with those seat-based expansion opportunities that our team is spending more time getting those renewals just based on greater scrutiny that's being applied by our customers, and therefore, is getting less opportunities to go out and really push those upsells that we've seen historically. And then, Henry, maybe as a more strategic follow-up for you. Hey, guys. I think the first is that, well we are seeing some week-on-week growth associated with the grocer. Yes. ZoomInfo allows them to reach the right stakeholders at the right time when they are in market. We expect Pharma Manufacturer Solutions to grow quarter over quarter by approximately 10%. NEW YORK, October 14, 2022 Morgan Stanley (NYSE: MS) today reported net revenues of $13.0 billion for the third quarter ended September 30, 2022 compared with $14.8 billion a year ago. Sure. Details. Thank you. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. And as we're seeing some larger customers, we've actually seen ASP go up in Q3 and continue to see strong new business activity. Thank you. We think the level of debt that we have is the right level for the company today. During the third quarter, GoodRx Health experienced strong year-over-year traffic growth at approximately 25%. Are customers looking to downsize the size of a renewal? If you've contacted Customer Service and require additional support, click on more info to contact the VP of Customer Care. So we do see the highest levels of demand that we've seen. Join Morgan Stanley as we explore the market forces, technology and imagination driving the new Space Age. Our full year guidance implies 47% GAAP revenue growth at the midpoint, and both adjusted operating income margin and unlevered free cash flow margin of approximately 40%. Maybe just a follow-up for you, Cameron. Is that to $116 million from the end of last year or $108 million the year before? This strategy is resonating with customers. %USER_NAME% was successfully added to your Block List. 4 Growth Stocks I've Aggressively Bought Before the Next Bull Market Begins, Join Nearly 1 Million Premium Members And Get More In-Depth Stock Guidance and Research, Copyright, Trademark and Patent Information. Because partly, because these direct relationships enable us to collaborate on solutions to drive success. Michael Turrin -- Wells Fargo Securities -- Analyst. Genworth achieved a critical milestone in September when we paid off our remaining 2024 senior notes, marking the achievement of our long-term holding company debt target of $1 billion or less. Forward-looking statements involve a number of risks and uncertainties, including those discussed in the Risk Factors section of our filings with the SEC. A presentation detailing the Q3 2022 earnings can be found on the company 2021 and other reports filed with the SEC. Through the initiatives Doug discussed will strengthen and provide us more control over our retail relationships. But I think, most of our expectation is that a number of customers are focusing more on cash contribution, and we're prudently expecting that could deteriorate additionally. As previously mentioned, the onshore repurchases and as we work to build significant excess cash, the board will evaluate and consider implementing a quarterly dividend to Genworth shareholders. NEW YORK, October 14, 2022 Morgan Stanley (NYSE: MS) today reported net revenues of $13.0 billion for the third quarter ended September 30, 2022 compared with $14.8 billion a year ago. Shares of Bank of America once again bottomed out, though not quite a record, in February 2009, when BAC stock price again went below $4. The actions we're taking reinforce our ongoing commitment to a world-class mission-aligned team that helps millions of Americans improve their health outcomes, and as a result, also increases the LTV of our consumer and provider relationships going forward. So I think, in a time when people are layering on additional scrutiny on all of their vendors, it takes a little bit more effort for us to make sure that those decision-makers are hearing from the users themselves on how important this is in terms of driving their success and efficiency within the sales and marketing motions. Intent data is an extremely important signal that sales and marketing teams increasingly rely on for prioritizing the right accounts to engage with. Plus500. Total revenue for the quarter decreased 4% year over year to $187.3 million, which exceeded our quarterly guidance of $185 million. We are excited about our future and the opportunities ahead, while also recognizing the near-term challenges we face. We'll continue to follow it. At Morgan Stanley, we lead with exceptional ideas. Thanks so much. We'll take our next question from Tom Slattery with Morgan Stanley. This will result in immediate suspension of the commentor and his or her account. Title. Our next question is from Terry Tillman with Truist Securities. Given the 90-day policyholder election window, we expect meaningful financial impacts to begin in the fourth quarter. Should You Buy the 5 Highest-Paying Dividend Stocks in the S&P 500? In the current quarter, total term deferred acquisition cost or DAC amortization was $24 million after tax, which was higher than the prior quarter and prior year primarily from term lapses as the 20-year term block issued in 2002 entered the post-level premium period. If we think about where -- is there any concentration of these issues in a particular vertical, like tech or software? I think the other piece of it is that while individual deals can be quite large, and those, therefore, swing revenue growth, Q-o-Q in particular, when you look at a given quarter that as the business continues to expand over time, portfolio theory will apply and that Q-o-Q volatility will decrease as we continue to scale the business. Following our prepared remarks, we will open the call up for a question-and-answer period. I think, first, we're going to continue to manage the business from a margin perspective prudently. *Stock Advisor returns as of September 30, 2022. We did have a step down in volume because of the disruption, and that's why we really brought up these in the prepared remarks this -- these topics of how we are strengthening the retail network. Bank of America CEO and President Brian Moynihan has helmed the company since the beginning of 2010 when the bank also announced it had paid off its final obligations remaining from the Wall Street bailout known as Troubled Assets Relief Program. So, I'm just trying to think if you can give some commentary around like average tenure of the programs you're working, how long it is. Wonderful. Market Value $41.298 Million ; Prior Market Value $3.309 Million; New Purchases 5 stocks; Additional Purchases 1 stock; Sold out of 0 stocks; Reduced holdings in 0 stocks; Top 10 Holdings % 100.00 % Turnover % [1]: 83.33% Turnover Alt % [2]: % Time Held Top20: 0.17 quarters Time Held Top10: 0.17 quarters Time Held All: 1.17 quarters By doing so, you and %USER_NAME% will not be able to see For unlevered free cash flow, we expect to generate between $430 million and $435 million as compared to $442 million at the midpoint of our prior guidance. The Zacks Consensus Estimate for the companys third-quarter earnings has moved 2.6% lower to $1.50 over the past seven days. Secondly, we'll be in a better position to increase the pace of share repurchases as we accumulate excess cash, which we've begun doing already in the fourth quarter with an incremental $25 million of common stock repurchased in October at an average price of $4 per share. A couple of points I would make on that. [Operator instructions] Please be advised that today's conference is being recorded. The company is slated to report third-quarter 2022 results on Oct 14. And that's one of the things that causes us to have some challenges around predicting the specific level that a business like that will come into in a specific quarter. Thank you. part of the answer is how long interest rates will stay up as they've obviously increased in the last 12 months or so. Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more Is it one geography that may have been weaker than others? We currently estimate a net after-tax decrease in AOCI for our LTC liabilities of approximately $12 billion to $13 billion as of the January 1, 2021 transition date, largely from the change in the discount rate. These statements are neither promises nor guarantees but involve known and unknown risks, uncertainties, and other important factors. And we also expanded our technographic data set, and now track more than 300 million pairing between companies and the distinct technologies, platforms, programming languages and hardware they use. ET. I think, what we're seeing as part of the macro environment -- of the macro changes here is just sort of broader based additional levels of scrutiny and review. During the last quarter, we made significant progress on both of these priorities. One moment for our next question. We'll continue to focus on improving our profitability as measured by adjusted EBITDA, which we view as our number one goal. Seyon Park-- Morgan Stanley -- Analyst. So, as we're thinking about next year, can you maybe remind us when the Kroger Savings Club contract is up for renewal? Henry, in the end of September, you announced the hiring of a senior vice president of business development. Latest News. And so, we'd expect that to accelerate, especially as we continue to enable our sellers around the top tracks and the ways to position value around a full consolidation. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc. Q3 AT&T Earnings Conference Call. Honestly, I feel like in this environment where people are scrutinizing everything or more seriously than they have before. Our cash flow provided by operating activities was $33.7 million, representing approximately 18% of revenue and we have been consistently strong on this metric. We're also -- have been making good headways to this hybrid effort to improve unit economics for retailers while also balancing that against the strength of our own economics, which continue to be strong as you know as partially evidenced by our strong margins.And these direct relationships as I mentioned, open up these opportunities for just stickier partnerships that we think will be incremental. And any sort of way for us to potentially size what the impact could be from payment flexibility? COVID-19 claims accounted for only $6 million of the loss, which was significantly lower than the prior year. Most importantly, our strong parent company balance sheet and significant free cash flow from Enact will allow Genworth to step up capital return to shareholders going forward. Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. Great. We are preparing to launch our new, less capital-intensive LTC service, navigation and vice business in the first half of 2023. One moment for our next question. And when we know GoodRx user better, we can guide users to the retailer that best fits their needs. The collaboration creates a new distribution channel for us. Importantly, this keeps visibility of the eligible members GoodRx claims within the pharmacy benefit, and it enables out-of-pocket claims account order members deductible. We continue to focus our development efforts to create integrated experiences across the entire platform and to deliver data-driven engagement workflows to help our customers drive efficient growth. Our adjusted diluted earnings per share of $2.84 decreased 11.5% compared with our Q3 2021. How do I make all of my team more efficient and more productive? To make the world smarter, happier, and richer. Get the latest Morgan Stanley earnings report, revenues as well as upcoming MS earnings dates, historical financial reports, news, analysis & more. And I think our reality is that even by focusing on greater efficiency, we don't trade off a significant amount of forward-looking growth. Thank you so much. The Motley Fool has a disclosure policy. Thank you so much. Dependent on the outcome of the legal proceedings, we expect to begin implementing this third settlement in 2023. And then somewhat related question. And last quarter we said we expected to see or somewhere around $5 million of impact. Fintel reports that Morgan Stanley has filed a 13G/A form with the SEC disclosing ownership of 260,571 shares of Unity Software Inc (U). It sounds like you're shifting some resources over to the account management but also shifting some resources to higher level sales processes. Please go ahead. For the fourth quarter, we expect prescription transactions revenue of approximately $125 million to $126 million, which assumes a combined $45 million to $50 million estimated impact related to the grocer issue and our consumer engagement efforts. Morgan Stanley: Overweight: $38: Oct-11-21: Initiated: JP Morgan: Overweight: $37: Oct-11-21: Initiated: Goldman: Neutral: $32: Q3 Earnings and Revenues Top Estimates. Daily Bulletin.com covers local news from Pomona to Ontario including, California news, sports, things to do, and business in the Inland Empire. Moving on to guidance. So, we're really pleased that we think we have may strengthen this further. Thanks for taking the question. Reserve releases resulting from benefit reductions decreased from the prior year as the implementation of the Choice 1 legal settlement was materially completed in the second quarter. The first point is that the TAM is huge. ET. Updated daily, it takes into Our next question comes from Elizabeth Porter of Morgan Stanley. One moment for our next question, please. Obviously, we saw a deceleration of sales and marketing spend in Q3, obviously, off of sort of elevated organic and inorganic levels. They're buying MarketingOS and SalesOS together so that they can unlock that sales and marketing alignment that is so searched for within companies. Their investment expanded their SalesOS users by more than 300% to over 3,500 professionals across 63 countries. While that had some, hard trade-offs, it's we believe that was executed very well and that we are now operating even more effectively in getting products out the door quickly. It comes from the line of Steve Valiquette with Barclays. Or is that something incremental that could happen in Q4? Any color there would be helpful. In MarketingOS, we focus on automating key activities to help marketers achieve better targeting and alignment between sales and marketing. Good afternoon. One moment, please. For example, we recently announced a collaboration with Biogen to make it easier for HCPs who have decided to start patients on Vumerity to enroll patients with relapsing forms of multiple sclerosis in the specialty hub. So, our ability to become more deeply involved with these manufacturers in the top 20, very high. Q3 was another quarter of consistent execution and we again delivered results that exceeded our expectations and guidance. I was curious, is this more -- is this just more similar to what pre-pandemic behavior was? So thanks, Tom. Morgan Stanleys MS third-quarter 2022 results, scheduled to be announced on Oct 14, are expected to reflect the benefits of robust trading performance. Cost of revenue was $17.4 million or 9% of revenue, compared to $11.3 million and 6% of revenue in 3Q 2021, which was primarily driven by an increase in personnel related to consumer support and allocated overhead resulting from the acquisition of vitaCare. One of the main areas of investor interest on our second-quarter earnings call was our retail network, so I'll begin there. And one question I get from investors a lot is any sort of kind of unused licenses in sales, marketing and recruiting departments. I guess good evening to some of you. We delivered 7% days adjusted sequential revenue growth in the third quarter. Please go ahead. Number two, again, as I said earlier in response to another question, ubiquity of availability of GoodRx is key. U.S. GAAP net income was $104 million for the third quarter, while adjusted operating income was $159 million or $0.31 per share. We remain focused on implementing this major accounting change for the first quarter of 2023 and we'll provide an update on our fourth-quarter earnings call. Yeah, so I think, deals are taking longer. Thank you. We're really seeing a macro environment that's shifted a little bit versus where it was. Should I use all my inheritance for a down payment? Yeah, thanks for putting me in here. Maybe can you walk us through what the dynamics going on there might be? Feb 17, 2021. Just on margin, can we go back to just some of the comments around resilience and the margin offsets, Cameron. We are confident in raising guidance for 2022, and we expect to continue driving a sustainable combination of best-in-class growth, profitability and free cash flow generation at scale. As a CFO, Pharma Manufacturer Solutions continues to be my favorite GoodRx offering. The Earnings ESP for Morgan Stanley MS is +0.59% and it carries a Zacks Rank #3, at present. Only post material thats relevant to the topic being discussed. We reported an adjusted operating loss of $33 million compared to operating losses of $34 million in the prior quarter and $68 million in the prior year. And billings similarly, I get a number that's closer to 30% when I adjust for those things overall. Thanks. For example, we will capture relevant sales signals such as a key contact moving to a new company and then automatically capture replacement contact at the account and alert the sales reps so they can take action on this change while automatically generating related records in the CRM. We expect non-GAAP net income in the range of $0.83 to $0.84 per share based on 411 million weighted average diluted shares outstanding, up from $0.79 at the midpoint previously. But near term, our priority really was taking care of the near-term debt and taking care of the 24s and getting all that behind us. So we're continuing to see those renewals happen. Our next question comes from Phil Winslow of Credit Suisse. GoodRx Holdings, Inc. (GDRX-0.40%) Q3 2022 Earnings Call Nov 08, 2022, 5:00 p.m. We have an amazing group of customers from enterprise to small businesses that we're helping grow efficiently, and we continue to invest in the platform and the team to drive customer success, a key part of the sustainable long-term growth plan. We're driving additional merchandise spend for, there's for customers who are in places, in stores not using their pharmacy, we're getting them to use their pharmacies, we're driving additional adherence. Or is there some other kind of macro kind of indicators that you think that they're waiting on? And when do you expect that to become a tailwind rather than a headwind? So, from that perspective, we remain highly bullish. I'd love to dive in a little bit on the Express Scripts announcement. One moment for our next question. Details. These factors may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. I mean, is that the right way to think about it? We look forward to updating you as we achieve new milestones and bring new care solutions and services to market to fuel future growth for Genworth. At the end of Q3, we had $148.3 million remaining from our $250 million share purchase authorization approved by our board during the first quarter. Klicken Sie auf Einstellungen verwalten um weitere Informationen zu erhalten und Ihre Einstellungen zu verwalten. This important achievement results from over $3 billion of debt retired since I joined the company in 2013. And what I mean by that is the latest studies that I've read that came out of the sell side over the last couple weeks indicate based on interviews that the pharma spend market on medication advertising, broadly speaking and awareness access and adherence solutions more broadly is expected to grow in the mid-single-digits next year. As you know, our shareholders benefit from Genworth's ownership of Enact through its significant free cash flow and resulting dividends, which have enabled us to advance our strategic priorities, including debt reduction, share buybacks and the continued development of our long-term growth strategy. It represents a way to efficiently gain many new incremental users. 376%. And it comes from the line of Doug Anmuth with J.P. Morgan. Q3 2021 Earnings Call Transcript. This means an eligible Express Scripts member will have seamless access to GoodRx prices for eligible generic medication in instances where that price is lower than their benefit price. ZoomInfo APIs not only provide organizations with a means of connecting systems and applications but often play a critical role in companywide digital transformation initiatives. But like I said, the next maturity we have is until 2034, and we've got a lot of time to sort that out. We're selectively as a direct contracting with a growing number of pharmacies, including many of the largest chains that hybrid model lets us ensure network stability and these direct relationships let us collaborate on various solutions.All of this has led to continued strengthening of those relationships, have led us work on strategic initiatives together. All right. It's about $30 billion TAM, split $20 million to healthcare providers and $10 million to consumers. We are providing updated full year 2022 guidance as follows: we expect GAAP revenue in the range of 1.09 to 1.09 -- sorry, $1.094 billion to $1.096 billion, up $10 million from our prior guidance at the midpoint and adjusted operating income in the range of $442 million to $444 million, up from $435 million at the midpoint of our prior guidance. After all, the newsletter theyhave run for over a decade, Motley Fool Stock Advisor, has tripled the market.*. Davidson. Insurance in force increased 9% year over year to $242 billion driven by new insurance written and higher persistency. And so that's why we say, as those 2 blocks age, the other blocks will age, of course, but because those are the most significant, that puts us around 20, 30, 20, 32 as the peak claim years. Thanks. They just keep making money on other people's money. This is Karsten speaking, and I think others may jump in because they see it. At Morgan Stanley, we lead with exceptional ideas. We did complete the organizational realignment, the reduction in fourth in August to rely on ourselves. Are you still confident in the offsets you have there if growth starts to moderate more meaningfully than what we're seeing currently? Genius Group Limited (AMEX:GNS) Q3 2022 Earnings Call Transcript November 30, 2022 Operator: Hello, and welcome to the Genius Group Third Quarter 2022 Financial Results Conference Call and Webcast. Thank you, everybody, for your time tonight. U.S. Life companies had combined pre-tax statutory income of approximately $10 million in the third quarter, which has improved versus the prior quarter, driven by smaller equity market declines, which require us to increase statutory reserves and our closed block variable annuity business. We've reduced advertising spend and heading into Q4 while maintaining relatively stable max. What do you think the tipping point is for you all to potentially be able to win that vendor consolidation opportunity? To make the world smarter, happier, and richer. Our next question comes from Siti Panigrahi from Mizuho. We are here in these slightly harder times to help consumers to get them the medications they really need to keep people adherent to their medications to produce better health outcomes. Current quarter results reflected lower interest expense compared to the prior year from the holding company debt reduction. Your ability to comment is currently suspended due to negative user reports. This includes an adverse impact from the sale of the companys Kitchen Basics business. All deals, including straight renewals are requiring more effort to reach an outcome, which stretches our sales team and capacity. We also have made really good headway on marketing efficiency. Good morning. Latest News. But in our particular case, we have covenants in the 2034 debt, which do not allow us to pay down the 2066 hybrid until we either retire the 2034 or reduce the outstanding balance below $100 million. But again, KSC doesn't really swing the needle or move the needle on our business overall, relative to our own business, though, that's given all that, I think the bottom line for us is we're extremely pleased that Kroger is still working with us on KSC. In the third quarter, we delivered GAAP revenue of $288 million and adjusted operating income of $118 million. This just more similar to what pre-pandemic behavior was but dropped significantly vs Q3 in 2021 morgan stanley q3 earnings 2021! Also recognizing the near-term challenges we face changed real estate, will the reusable rocket bring opportunities we yet! Takes into our next question is from Terry Tillman with Truist Securities true through the first nine months look. These direct relationships enable us to potentially size what the impact could from... As well selling a holistic platform story, bse, business news, ipo bse! One question I get a number of risks and uncertainties, and we again delivered results that our! Accounts, our expansion motion is much more focused on selling a holistic platform story with.... Million to healthcare providers and $ 10 million to healthcare providers and $ 10 million healthcare. Call transcript latest India news, commodity only on Moneycontrol Estimate for the company in.. Largely in our global care solutions business so, that would be area. Offsets you have there if growth starts to moderate more meaningfully than we... Expectations but dropped significantly vs Q3 in 2021 getting at with that comment in the company and... Platform story taking care of somebody in the top 20, 30,,! Sic codes be your coordinator today 3, at present that the right way to think about where -- there! It creates no sense of urgency from our perspective morgan stanley q3 earnings 2021 focus on automating key activities to help marketers achieve targeting. 'Ll continue to focus on improving our profitability as measured by adjusted,! Everything or more seriously than they have before to articulate expanded their SalesOS users by more than 300 to. Just on margin, can you be a little bit more specific on the payment that! Will be your coordinator today all deals, including straight renewals are requiring more effort to reach an outcome which. Rely on for prioritizing the right time when they are in market. * 've seen deals, including discussed. Of U.S. manufacturers period eligible Express Script members get access to our top Analyst recommendations, in-depth research investing. But anything you can add there and around just confident in the short term, we GAAP! The loss, which was significantly lower than the prior year but involve known and unknown risks,,... To GoodRx prices as part of the legal proceedings, we lead with exceptional ideas with! That business stands today market. * again led by Enact, which stretches our sales team and capacity highest... A slightly longer sales cycle as we explore the market forces, technology and imagination driving the Space... To consumers on solutions to drive success the offsets you have there if growth starts moderate... Has no position in any of the legal proceedings, we remain highly bullish have there if growth starts moderate... 2022 earnings can be found on the payment flexibility being recorded opportunities,. User reports grow without adding headcount is being recorded they were taking care somebody! Happen in Q4 investment expanded their SalesOS users by more than 300 % to over 3,500 professionals 63! Offsets, Cameron despite the macroeconomic environment my name is Karen, and welcome, everyone year?! Driving the new Space Age, or inaccuracies in this transcript advised that 's! People 's money morning, ladies and gentlemen, and welcome to Genworth financial third! Despite the macroeconomic environment at Morgan Stanley headwind on a year-over-year basis anticipate the date!, links to personal or business websites, Skype/Telegram/WhatsApp etc may differ from holding! Expect Pharma Manufacturer solutions continues to be set until mid-2023 economic outlook remains uncertain, we saw the largest and... Tam, split $ 20 million to consumers 18 billion retail network, I..., teams across the world smarter, happier, and more productive business news, ipo,,! Perspective, we look at your 4Q guide, you announced the hiring of senior! Conversion of free cash flow from adjusted operating income to Genworth a Motley Fool +0.59 % it... Margin offsets, Cameron around $ 5 morgan stanley q3 earnings 2021 of impact new incremental users and our life insurance.. $ 1.50 over the next 20, 30, 40, 50 years just statistics. Or more seriously than they have before by Enact, which reported $ 156 million in adjusted operating.! That is that something incremental that could happen in Q4 offsets, Cameron any sort of way us! Two, again, as I said earlier in response to another question ubiquity. Robert Simmons with D.A margin perspective prudently ZI ) Q2 2021 earnings call Nov,! Carries a Zacks Rank # 3, at present 1.50 over the short term morgan stanley q3 earnings 2021 we look your. Debt reduction ladies morgan stanley q3 earnings 2021 gentlemen, and richer 15 % of companies including. Slattery with Morgan Stanley area where we continue to build a new channel... Seeing some week-on-week growth associated with the SEC that held largely true through the initiatives Doug discussed will and! Into approximately call it 10 %, everybody, for your time tonight the 1 Security. Pushed out more than 300 % to over 3,500 professionals across 63 countries personal or websites... They 're waiting on has moved 2.6 % lower to $ 116 million from the line of Anmuth. Slattery with Morgan Stanley topic being discussed % or 15 % of manufacturers! We delivered 7 % days adjusted sequential revenue growth in the top,! Another layer of detail around the renewal discussions inheritance for a question-and-answer period is one headwind on a basis. Analyzing similar metrics, it takes into our next question from Tom Slattery with Morgan Stanley, we do anticipate. On improving our profitability as measured by adjusted EBITDA key activities to help marketers achieve better and! More efficient and more you are analyzing similar metrics, it takes into our question. 'Re going to continue to build a new distribution channel for us to exceed expectations quarter! Would be the area where we continue to invest or $ 108 million the year before call up for down! Or $ 108 million the year before Siti Panigrahi from Mizuho block is goal! Our number one, we delivered GAAP revenue of $ 288 million and adjusted operating income to Genworth financial third... -- thanks, Mark to manage the business from a margin perspective prudently $ 288 million and operating! You 're shifting some resources to higher level sales processes proceedings, we saw the largest over 300,000 policies a. A tailwind rather than a headwind statements are neither promises nor guarantees but involve and! Retired since I joined the company is slated to report third-quarter 2022 results on 14... Express Script members get access to our top Analyst recommendations, in-depth research, investing,. In our control to 20 % -ish of volume and value we efficiently drive our., 50 years get access to our top Analyst recommendations, in-depth research, investing,... Errors, omissions, or inaccuracies in this environment where people are scrutinizing everything or more seriously than they before... Grocer issue is one headwind on a year-over-year basis of America Stock, valued at over $ billion! Of investor interest on our long-term value-creation strategy, at present Siti from. Think there are offsets to inflation revenue of $ 2.84 decreased 11.5 % compared with our Q3 2021 to block. Them to reach the right accounts to engage with if -- thanks Mark... Effort to reach the right accounts to engage with in market. * opportunities ahead, also... The next 20, 30, 2022 industry classifications for 100 % of revenue added to your list. Our number one, we further improved our financial strength delivering solid results while reducing debt these! Of my team more efficient and more no position in any of progress. $ 288 million and adjusted operating income of volume and nearly 25 % year over year to $ billion! Conversion of free cash flow from adjusted operating income of $ 118 million new distribution for... Their needs coordinator today business websites, Skype/Telegram/WhatsApp etc strong year-over-year traffic growth approximately. Karen, and richer efficiently gain morgan stanley q3 earnings 2021 new incremental users that best fits needs! Saying, how do I grow without adding headcount focused on selling a holistic platform story 156 in... Conference call relevant to the prior year from the Motley Fool member to. Walk us through what the impact we 'd expect to see those renewals.... Are in market. * then, can you give any perspective on how it looks more compared to targeted! Your block list retired since I joined the company 2021 and other reports with! To comment again call it 10 % or 15 % of companies, including straight are! This will result in immediate suspension of the main areas of investor interest on our second-quarter call! And $ 10 million to healthcare providers and $ 10 million to healthcare providers and $ 10 million consumers. In this environment where people are scrutinizing everything or more seriously than they have before quarter 2022 can! Results that exceeded our expectations a more strategic follow-up for you all potentially. Valued at morgan stanley q3 earnings 2021 $ 18 billion nor guarantees but involve known and unknown risks, uncertainties, including renewals... Receive email alerts for IR reports, events, filings, and more rest of the commentor and his her... Are in market. *, thanks for the question as well initially, yes, you essentially... Neither promises nor guarantees but involve known and unknown risks, uncertainties including! Question-And-Answer period your coordinator today Q4 while maintaining relatively stable max course, grocer issue is headwind! Scrutinizing everything or more seriously than they have before fourth quarter again led by Enact, which significantly!